Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Diabetes

  Free Subscription


17.06.2019

1 Am J Hypertens
2 Am J Ophthalmol
1 Atherosclerosis
1 Biochem Biophys Res Commun
1 Br J Ophthalmol
2 Circulation
4 Diabet Med
3 Diabetes
14 Diabetes Care
2 Diabetes Educ
4 Diabetes Obes Metab
6 Diabetologia
2 Eur J Endocrinol
1 Hypertension
1 Invest Ophthalmol Vis Sci
1 J Autoimmun
1 J Biol Chem
1 J Clin Endocrinol Metab
7 J Diabetes Complications
1 J Nutr
4 Lancet
8 Lancet Diabetes Endocrinol
3 N Engl J Med
1 Nat Genet
2 Ophthalmol Retina
2 Pediatr Diabetes
1 PLoS Genet
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Retina


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hypertens

  1. PSATY BM, Fleming TR
    Cardiovascular safety trials of antidiabetic therapies to treat type 2 diabetes: perhaps asking the wrong question?
    Am J Hypertens. 2019 Jun 7. pii: 5512981. doi: 10.1093.
    PubMed     Text format    


    Am J Ophthalmol

  2. VAIL D, Callaway NF, Ludwig CA, Saroj N, et al
    Lipid-Lowering Medications are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among U.S. Patients with Diabetes.
    Am J Ophthalmol. 2019 Jun 10. pii: S0002-9394(19)30264.
    PubMed     Text format     Abstract available

  3. RUSSELL JF, Flynn HW Jr, Sridhar J, Townsend JH, et al
    Distribution of Diabetic Neovascularization on Ultra-Widefield Fluorescein Angiography and on Simulated Widefield OCT Angiography.
    Am J Ophthalmol. 2019 Jun 10. pii: S0002-9394(19)30266.
    PubMed     Text format     Abstract available


    Atherosclerosis

  4. DE SILVA GS, Desai K, Darwech M, Naim U, et al
    Circulating serum fatty acid synthase is elevated in patients with diabetes and carotid artery stenosis and is LDL-associated.
    Atherosclerosis. 2019;287:38-45.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  5. KALIYAPERUMAL R, Deng X, Meiselman HJ, Song H, et al
    Depletion interaction forces contribute to erythrocyte-endothelial adhesion in diabetes.
    Biochem Biophys Res Commun. 2019 Jun 11. pii: S0006-291X(19)31135.
    PubMed     Text format     Abstract available


    Br J Ophthalmol

  6. KASE S, Endo H, Takahashi M, Saito M, et al
    Alteration of choroidal vascular structure in diabetic retinopathy.
    Br J Ophthalmol. 2019 Jun 8. pii: bjophthalmol-2019-314273.
    PubMed     Text format     Abstract available


    Circulation

  7. ARNOLD SV, de Lemos JA, Rosenson RS, Ballantyne CM, et al
    Use of Guideline-Recommended Risk-Reduction Strategies Among Patients with Diabetes and Atherosclerotic Cardiovascular Disease: Insights from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOUL
    Circulation. 2019 Jun 7. doi: 10.1161/CIRCULATIONAHA.119.041730.
    PubMed     Text format     Abstract available

  8. KRONLAGE M, Dewenter M, Grosso J, Fleming T, et al
    O-GlcNAcylation of Histone Deacetylase 4 Protects the Diabetic Heart from Failure.
    Circulation. 2019 Jun 14. doi: 10.1161/CIRCULATIONAHA.117.031942.
    PubMed     Text format     Abstract available


    Diabet Med

  9. AKTURK HK, Kahramangil D, Sarwal A, Hoffecker L, et al
    Immune checkpoint inhibitor-induced Type 1 diabetes: a systematic review and meta-analysis.
    Diabet Med. 2019 Jun 14. doi: 10.1111/dme.14050.
    PubMed     Text format     Abstract available

  10. NOLAN J, Rush A, Kaye J
    Glycaemic stability of a cyclist with Type 1 diabetes: 4011 km in 20 days on a ketogenic diet.
    Diabet Med. 2019 Jun 14. doi: 10.1111/dme.14049.
    PubMed     Text format     Abstract available

  11. WYLIE TAF, Shah C, Connor R, Farmer AJ, et al
    Transforming mental well-being for people with diabetes: research recommendations from Diabetes UK's 2019 Diabetes and Mental Well-Being Workshop.
    Diabet Med. 2019 Jun 8. doi: 10.1111/dme.14048.
    PubMed     Text format     Abstract available

  12. FORD CN, Leet RW, Daniels L, Rhee MK, et al
    Racial differences in performance of HbA1c for the classification of diabetes and prediabetes among US adults of non-Hispanic black and white race.
    Diabet Med. 2019 Jun 12. doi: 10.1111/dme.13979.
    PubMed     Text format     Abstract available


    Diabetes


  13. Effects of Treatment of Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes With Metformin Alone or in Combination With Insulin Glargine on beta-Cell Function: Comparison of Responses In Youth And Adults.
    Diabetes. 2019 Jun 9. pii: db19-0299. doi: 10.2337/db19-0299.
    PubMed     Text format     Abstract available

  14. FINAN B, Capozzi ME, Campbell JE
    Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes.
    Diabetes. 2019 Jun 9. pii: dbi19-0004. doi: 10.2337/dbi19-0004.
    PubMed     Text format     Abstract available

  15. BAKER RL, Rihanek M, Hohenstein AC, Nakayama M, et al
    Hybrid Insulin Peptides are Autoantigens in Type 1 Diabetes.
    Diabetes. 2019 Jun 7. pii: db19-0128. doi: 10.2337/db19-0128.
    PubMed     Text format     Abstract available


    Diabetes Care

  16. DOUROS A, Rouette J, Yin H, Yu OHY, et al
    Dipeptidyl Peptidase-4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes.
    Diabetes Care. 2019 Jun 10. pii: dc19-0409. doi: 10.2337/dc19-0409.
    PubMed     Text format     Abstract available

  17. ZONG G, Liu G, Willett WC, Wanders AJ, et al
    Associations Between Linoleic Acid Intake and Incident Type 2 Diabetes Among U.S. Men and Women.
    Diabetes Care. 2019 Jun 10. pii: dc19-0412. doi: 10.2337/dc19-0412.
    PubMed     Text format     Abstract available


  18. Lack of Durable Improvements in beta-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes.
    Diabetes Care. 2019 Jun 9. pii: dc19-0556. doi: 10.2337/dc19-0556.
    PubMed     Text format     Abstract available

  19. PRATTE KA, Johnson A, Beals J, Bullock A, et al
    Regression to Normal Glucose Regulation in American Indians and Alaska Natives of a Diabetes Prevention Program.
    Diabetes Care. 2019 Jun 8. pii: dc18-1964. doi: 10.2337/dc18-1964.
    PubMed     Text format     Abstract available

  20. BEHARY P, Tharakan G, Alexiadou K, Johnson N, et al
    Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized Single-Blinded Placebo Controlled Study.
    Diabetes Care. 2019 Jun 8. pii: dc19-0449. doi: 10.2337/dc19-0449.
    PubMed     Text format     Abstract available

  21. NAM GE, Park YG, Han K, Kim MK, et al
    BMI, Weight Change, and Dementia Risk in Patients With New-Onset Type 2 Diabetes: A Nationwide Cohort Study.
    Diabetes Care. 2019 Jun 8. pii: dc18-1667. doi: 10.2337/dc18-1667.
    PubMed     Text format     Abstract available

  22. TEMPLE KA, Tjaden AH, Atkinson KM, Barengolts E, et al
    Association of Habitual Daily Physical Activity With Glucose Tolerance and beta-Cell Function in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes From the Restoring Insulin Secretion (RISE) Study.
    Diabetes Care. 2019 Jun 8. pii: dc19-0538. doi: 10.2337/dc19-0538.
    PubMed     Text format     Abstract available

  23. HOME P
    Controversies for Glucose Control Targets in Type 2 Diabetes: Exposing the Common Ground.
    Diabetes Care. 2019 Jun 8. pii: dci19-0002. doi: 10.2337/dci19-0002.
    PubMed     Text format     Abstract available

  24. PERKINS BA, Rosenstock J, Skyler JS, Laffel LM, et al
    Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 Diabetes.
    Diabetes Care. 2019 Jun 8. pii: dc19-0548. doi: 10.2337/dc19-0548.
    PubMed     Text format     Abstract available

  25. BASTERRA-GORTARI FJ, Ruiz-Canela M, Martinez-Gonzalez MA, Babio N, et al
    Effects of a Mediterranean Eating Plan on the Need for Glucose-Lowering Medications in Participants With Type 2 Diabetes: A Subgroup Analysis of the PREDIMED Trial.
    Diabetes Care. 2019 Jun 10. pii: dc18-2475. doi: 10.2337/dc18-2475.
    PubMed     Text format     Abstract available

  26. FAN J, Yin S, Lin D, Liu Y, et al
    Association of Serum Retinol-Binding Protein 4 Levels and the Risk of Incident Type 2 Diabetes in Subjects With Prediabetes.
    Diabetes Care. 2019 Jun 11. pii: dc19-0265. doi: 10.2337/dc19-0265.
    PubMed     Text format     Abstract available

  27. AFKARIAN M, Polsky S, Parsa A, Aronson R, et al
    PERL in Diabetes Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data.
    Diabetes Care. 2019 Jun 11. pii: dc19-0342. doi: 10.2337/dc19-0342.
    PubMed     Text format     Abstract available

  28. ARODA VR, Rosenstock J, Terauchi Y, Altuntas Y, et al
    PIONEER 1: Randomized Clinical Trial Comparing the Efficacy and Safety of Oral Semaglutide Monotherapy with Placebo in Patients with Type 2 Diabetes.
    Diabetes Care. 2019 Jun 11. pii: dc19-0749. doi: 10.2337/dc19-0749.
    PubMed     Text format     Abstract available

  29. MUHAMMAD IF, Borne Y, Bao X, Melander O, et al
    Circulating HER2/ErbB2 Levels Are Associated With Increased Incidence of Diabetes: A Population-Based Cohort Study.
    Diabetes Care. 2019 Jun 14. pii: dc18-2556. doi: 10.2337/dc18-2556.
    PubMed     Text format     Abstract available


    Diabetes Educ

  30. AGA FB, Dunbar SB, Kebede T, Higgins MK, et al
    Correlates of Self-Care Behaviors in Adults With Type 2 Diabetes and Comorbid Heart Failure.
    Diabetes Educ. 2019 Jun 14:145721719855752. doi: 10.1177/0145721719855752.
    PubMed     Text format     Abstract available

  31. FAIN JA
    Embracing a New Vision for Diabetes Education and Diabetes Educators.
    Diabetes Educ. 2019 Jun 14:145721719859482. doi: 10.1177/0145721719859482.
    PubMed     Text format    


    Diabetes Obes Metab

  32. GOLDENBERG RM, Gilbert JD, Hramiak IM, Woo VC, et al
    SGLT inhibitors in type 1 diabetes: place in therapy and a risk mitigation strategy for preventing diabetic ketoacidosis - the STOP DKA Protocol.
    Diabetes Obes Metab. 2019 Jun 10. doi: 10.1111/dom.13811.
    PubMed     Text format     Abstract available

  33. SABATINE MS, Giugliano RP, Leiter LA
    Correctly Understanding the Diabetes Data in FOURIER.
    Diabetes Obes Metab. 2019 Jun 10. doi: 10.1111/dom.13812.
    PubMed     Text format     Abstract available

  34. JOHANSEN ML, Schou M, Rossignol P, Holm MR, et al
    Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial (MIRAD trial).
    Diabetes Obes Metab. 2019 Jun 10. doi: 10.1111/dom.13809.
    PubMed     Text format     Abstract available

  35. MELMER A, Zuger T, Lewis DM, Leibrand S, et al
    Glycemic Control in Individuals with Type 1 Diabetes Using an Open Source Artificial Pancreas System (OpenAPS).
    Diabetes Obes Metab. 2019 Jun 10. doi: 10.1111/dom.13810.
    PubMed     Text format     Abstract available


    Diabetologia

  36. AZMI S, Jeziorska M, Ferdousi M, Petropoulos IN, et al
    Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation.
    Diabetologia. 2019 Jun 7. pii: 10.1007/s00125-019-4897.
    PubMed     Text format     Abstract available

  37. TYNDALL V, Stimson RH, Zammitt NN, Ritchie SA, et al
    Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes.
    Diabetologia. 2019 Jun 9. pii: 10.1007/s00125-019-4894.
    PubMed     Text format     Abstract available

  38. BRAHIMAJ A, Rivadeneira F, Muka T, Sijbrands EJG, et al
    Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study.
    Diabetologia. 2019 Jun 10. pii: 10.1007/s00125-019-4921.
    PubMed     Text format     Abstract available

  39. ABBASI A, Corpeleijn E, Meijer E, Postmus D, et al
    Correction to: Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
    Diabetologia. 2019 Jun 12. pii: 10.1007/s00125-019-4917.
    PubMed     Text format     Abstract available

  40. ABDULREDA MH, Molano RD, Faleo G, Lopez-Cabezas M, et al
    Correction to: In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice.
    Diabetologia. 2019 Jun 12. pii: 10.1007/s00125-019-4922.
    PubMed     Text format     Abstract available

  41. JENUM AK, Brekke I, Mdala I, Muilwijk M, et al
    Effects of dietary and physical activity interventions on the risk of type 2 diabetes in South Asians: meta-analysis of individual participant data from randomised controlled trials.
    Diabetologia. 2019 Jun 15. pii: 10.1007/s00125-019-4905.
    PubMed     Text format     Abstract available


    Eur J Endocrinol

  42. SINN DH, Kang D, Cho SJ, Paik SW, et al
    Lean non-alcoholic fatty liver disease and development of diabetes: A cohort study.
    Eur J Endocrinol. 2019 Jun 1. pii: EJE-19-0143.R1. doi: 10.1530/EJE-19-0143.
    PubMed     Text format     Abstract available

  43. HYGUM K, Starup-Linde JK, Harslof T, Joergensen NR, et al
    The diurnal variation of bone formation is attenuated in adult patients with type 2 diabetes.
    Eur J Endocrinol. 2019 Jun 1. pii: EJE-19-0309.R1. doi: 10.1530/EJE-19-0309.
    PubMed     Text format     Abstract available


    Hypertension

  44. YOUNG BE, Holwerda SW, Vranish JR, Keller DM, et al
    Sympathetic Transduction in Type 2 Diabetes Mellitus.
    Hypertension. 2019;74:201-207.
    PubMed     Text format     Abstract available


    Invest Ophthalmol Vis Sci

  45. CARROLL LS, Uehara H, Fang D, Choi S, et al
    Intravitreal AAV2.COMP-Ang1 Attenuates Deep Capillary Plexus Expansion in the Aged Diabetic Mouse Retina.
    Invest Ophthalmol Vis Sci. 2019;60:2494-2502.
    PubMed     Text format     Abstract available


    J Autoimmun

  46. TENSPOLDE M, Zimmermann K, Weber LC, Hapke M, et al
    Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
    J Autoimmun. 2019 Jun 5. pii: S0896-8411(19)30165.
    PubMed     Text format     Abstract available


    J Biol Chem

  47. LI Y, Cooper A, Odibo IN, Ahmed A, et al
    Withdrawal: Discrepancy in insulin regulation between gestational diabetes mellitus (GDM) platelets and placenta.
    J Biol Chem. 2019;294:9656.
    PubMed     Text format    


    J Clin Endocrinol Metab

  48. HO J, Nicolucci AC, Virtanen H, Schick A, et al
    Effect of prebiotic on microbiota, intestinal permeability and glycemic control in children with type 1 diabetes.
    J Clin Endocrinol Metab. 2019 Jun 12. pii: 5513497. doi: 10.1210/jc.2019-00481.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  49. WEEDA ER, Cassarly C, Brinton DL, Shirley DW, et al
    Loop diuretic use among patients with heart failure and type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors.
    J Diabetes Complications. 2019 May 10. pii: S1056-8727(19)30245.
    PubMed     Text format     Abstract available

  50. KUO KT, Chang YF, Wu IH, Lu FH, et al
    Differences in the association between glycemia and uric acid levels in diabetic and non-diabetic populations.
    J Diabetes Complications. 2019 May 11. pii: S1056-8727(19)30054.
    PubMed     Text format     Abstract available

  51. SAULNIER PJ, Briet C, Gand E, Chaillous L, et al
    No association between fear of hypoglycemia and blood glucose variability in type 1 diabetes: The cross-sectional VARDIA study.
    J Diabetes Complications. 2019 May 10. pii: S1056-8727(18)30904.
    PubMed     Text format     Abstract available

  52. SCALZO RL, Rafferty D, Schauer I, Huebschmann AG, et al
    Sitagliptin improves diastolic cardiac function but not cardiorespiratory fitness in adults with type 2 diabetes.
    J Diabetes Complications. 2019 May 10. pii: S1056-8727(18)31409.
    PubMed     Text format     Abstract available

  53. TAKAO T, Matsuyama Y, Suka M, Yanagisawa H, et al
    Analysis of the duration and extent of the legacy effect in patients with type 2 diabetes: A real-world longitudinal study.
    J Diabetes Complications. 2019 May 10. pii: S1056-8727(19)30295.
    PubMed     Text format     Abstract available

  54. NADRI G, Saxena S, Stefanickova J, Ziak P, et al
    Disorganization of retinal inner layers correlates with ellipsoid zone disruption and retinal nerve fiber layer thinning in diabetic retinopathy.
    J Diabetes Complications. 2019 May 17. pii: S1056-8727(19)30249.
    PubMed     Text format     Abstract available

  55. BJORNSTAD P, Lovshin JA, Lytvyn Y, Lovblom LE, et al
    Elevated plasma cyclic guanosine monophosphate may explain greater efferent arteriolar tone in adults with longstanding type 1 diabetes: A brief report.
    J Diabetes Complications. 2019 May 17. pii: S1056-8727(19)30420.
    PubMed     Text format     Abstract available


    J Nutr

  56. PRENTICE RL, Aragaki AK, Howard BV, Chlebowski RT, et al
    Low-Fat Dietary Pattern among Postmenopausal Women Influences Long-Term Cancer, Cardiovascular Disease, and Diabetes Outcomes.
    J Nutr. 2019 Jun 8. pii: 5512736. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet

  57. GERSTEIN HC, Colhoun HM, Dagenais GR, Diaz R, et al
    Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
    Lancet. 2019 Jun 7. pii: S0140-6736(19)31149.
    PubMed     Text format     Abstract available

  58. PRATLEY R, Amod A, Hoff ST, Kadowaki T, et al
    Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial.
    Lancet. 2019 Jun 7. pii: S0140-6736(19)31271.
    PubMed     Text format     Abstract available

  59. GERSTEIN HC, Colhoun HM, Dagenais GR, Diaz R, et al
    Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
    Lancet. 2019 Jun 7. pii: S0140-6736(19)31150.
    PubMed     Text format     Abstract available

  60. VERMA S, Mazer CD, Perkovic V
    Is it time to REWIND the cardiorenal clock in diabetes?
    Lancet. 2019 Jun 7. pii: S0140-6736(19)31267.
    PubMed     Text format    


    Lancet Diabetes Endocrinol

  61. MOSENZON O, Wiviott SD, Cahn A, Rozenberg A, et al
    Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.
    Lancet Diabetes Endocrinol. 2019 Jun 10. pii: S2213-8587(19)30180.
    PubMed     Text format     Abstract available

  62. PIEBER TR, Bode B, Mertens A, Cho YM, et al
    Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.
    Lancet Diabetes Endocrinol. 2019 Jun 6. pii: S2213-8587(19)30194.
    PubMed     Text format     Abstract available

  63. ARODA VR, Gonzalez-Galvez G, Gron R, Halladin N, et al
    Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial.
    Lancet Diabetes Endocrinol. 2019 Jun 7. pii: S2213-8587(19)30184.
    PubMed     Text format     Abstract available

  64. MOSENZON O, Blicher TM, Rosenlund S, Eriksson JW, et al
    Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial.
    Lancet Diabetes Endocrinol. 2019 Jun 6. pii: S2213-8587(19)30192.
    PubMed     Text format     Abstract available

  65. NAUCK MA, Meier JJ
    Pioneering oral peptide therapy for patients with type 2 diabetes.
    Lancet Diabetes Endocrinol. 2019 Jun 6. pii: S2213-8587(19)30182.
    PubMed     Text format    

  66. KEHLENBRINK S, Jaacks LM
    Diabetes in humanitarian crises: the Boston Declaration.
    Lancet Diabetes Endocrinol. 2019 Jun 6. pii: S2213-8587(19)30197.
    PubMed     Text format    

  67. MIRAS AD, Perez-Pevida B, Aldhwayan M, Kamocka A, et al
    Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial.
    Lancet Diabetes Endocrinol. 2019 Jun 4. pii: S2213-8587(19)30157.
    PubMed     Text format     Abstract available

  68. MINGRONE G
    Treatment of persistent or recurrent type 2 diabetes after metabolic surgery.
    Lancet Diabetes Endocrinol. 2019 Jun 4. pii: S2213-8587(19)30195.
    PubMed     Text format    


    N Engl J Med

  69. ROSEN CJ, Ingelfinger JR
    Traveling down the Long Road to Type 1 Diabetes Mellitus Prevention.
    N Engl J Med. 2019 Jun 9. doi: 10.1056/NEJMe1907458.
    PubMed     Text format    

  70. HEROLD KC, Bundy BN, Long SA, Bluestone JA, et al
    An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
    N Engl J Med. 2019 Jun 9. doi: 10.1056/NEJMoa1902226.
    PubMed     Text format     Abstract available

  71. HUSAIN M, Birkenfeld AL, Donsmark M, Dungan K, et al
    Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2019 Jun 11. doi: 10.1056/NEJMoa1901118.
    PubMed     Text format     Abstract available


    Nat Genet

  72. WARRINGTON NM, Beaumont RN, Horikoshi M, Day FR, et al
    Maternal and fetal genetic effects on birth weight and their relevance to cardio-metabolic risk factors.
    Nat Genet. 2019;51:804-814.
    PubMed     Text format     Abstract available


    Ophthalmol Retina

  73. MEHANNA CJ, Abdul Fattah M, Haddad S, Tamim H, et al
    Anti-VEGF Therapy for Persistent Neovascularization after Complete Panretinal Photocoagulation in Proliferative Diabetic Retinopathy.
    Ophthalmol Retina. 2019;3:473-477.
    PubMed     Text format     Abstract available

  74. FALAVARJANI KG, Hadi Y, Habibi A, Anvari P, et al
    Efficacy of Topical Timolol Eye Drops for the Treatment of Diabetic Macular Edema.
    Ophthalmol Retina. 2019;3:538-539.
    PubMed     Text format    


    Pediatr Diabetes

  75. WINKLER C, Haupt F, Heigermoser M, Zapardiel-Gonzalo J, et al
    Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results.
    Pediatr Diabetes. 2019 Jun 13. doi: 10.1111/pedi.12870.
    PubMed     Text format     Abstract available

  76. CHERUBINI V, Rabbone I, Lombardo F, Mossetto G, et al
    Incidence of severe hypoglycemia and possible associated factors in pediatric patients with type 1 diabetes mellitus in the real-life, post-DCCT setting: a systematic review.
    Pediatr Diabetes. 2019 Jun 8. doi: 10.1111/pedi.12876.
    PubMed     Text format     Abstract available


    PLoS Genet

  77. MATTNER J, Mohammed JP, Fusakio ME, Giessler C, et al
    Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice.
    PLoS Genet. 2019;15:e1008178.
    PubMed     Text format     Abstract available


    PLoS One

  78. OSE D, Kamradt M, Kiel M, Freund T, et al
    Care management intervention to strengthen self-care of multimorbid patients with type 2 diabetes in a German primary care network: A randomized controlled trial.
    PLoS One. 2019;14:e0214056.
    PubMed     Text format     Abstract available

  79. SUNNY AK, Khanal VK, Sah RB, Ghimire A, et al
    Depression among people living with type 2 diabetes in an urbanizing community of Nepal.
    PLoS One. 2019;14:e0218119.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  80. SORINI C, Cosorich I, Lo Conte M, De Giorgi L, et al
    Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes.
    Proc Natl Acad Sci U S A. 2019 Jun 10. pii: 1814558116.
    PubMed     Text format     Abstract available


    Retina

  81. AJLAN RS, Barnard LR, Mainster MA
    NONCONFOCAL ULTRA-WIDEFIELD SCANNING LASER OPHTHALMOSCOPY: Polarization Artifacts and Diabetic Macular Edema.
    Retina. 2019 Jun 4. doi: 10.1097/IAE.0000000000002588.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: